OB/GYN Clinical Alert – February 1, 2007
February 1, 2007
View Issues
-
Decline in Breast Cancer and Reduced Use of Hormone Therapy
Ravdin and colleagues from the University of Texas M.D. Anderson Cancer Center reported a 7% decrease (14,000 fewer cases) in the incidence of breast cancer in 9 regions of the U.S. in 2003. -
Breast Cancer Risk in Finnish Women Using Estrogen-Only Therapy
Lyytinen and colleagues from Helsinki reported the results of a cohort study assessing the risk of breast cancer in postmenopausal Finnish women using oral, transdermal, and vaginal estrogen products containing either estradiol or estriol. -
Pregnancy after Uterine artery embolization for uterine fibroids
In a recent paper, Walker and McDowell contacted 1200 patients having had this procedure since 1996 at either the Royal Surrey County Hospital or the London clinic. One hundred eight women had tried to become pregnant and 33 succeeded at least once. In total, the authors had data on 56 completed pregnancies. -
Additional support OCP's reduce ovarian cancer risk
Women with pathogenic mutations in BRCA1 or BRCA2 are known to be at substantially higher lifetime risk for ovarian and breast cancer than the general population. The degree to which reproductive factors affect this risk has been estimated but is limited by studies of small sample size or faulty methodology. -
How Best to Medically Manage Ectopic Pregnancy?
These Iranian investigators randomized treatment of 108 patients with unruptured ectopic pregnancy to either a single dose protocol or a multiple dose protocol. The single dose regimen was successful in 48/54 cases (88.9%), while 92.6% (50/54) patients responded to the multiple-dose regimen. -
Phenotypic Differences between Male Physicians, Surgeons, and Film Stars: Comparative Study
The investigators enticed 14 male surgeons and 16 male physicians (internal medicine and sub-specialists) to submit recent photographs of themselves to the investigators and to indicate how tall they were. -
Pharmacology Watch: Breast Cancer Rates Have Dropped Since WHI of 2002
Herbal Supplements to Treat Vasomotor Symptoms; Bisphosphonates to Treat LBD, After 5 Years?; FDA Actions -
Clinical Briefs in Primary Care supplement